corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 19363

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Galloway G
House approves generic-drug bill meant to help poor countries
The Globe and Mail 2011 Mar 10
http://www.theglobeandmail.com/news/politics/house-approves-generic-drug-bill-meant-to-help-poor-countries/article1935976/


Full text:

A long-running attempt to make it easier to produce and distribute copies of patented medicines for sale at cut-rate prices to the world’s poorest countries has been approved by the House of Commons.

A private-member’s bill known as C-393, which has gained the support of some Canadian celebrities including the musician K’naan and writer Margaret Atwood, is now headed to the Conservative-dominated Senate.

“If I look at the kind of fortunes that I (have), it compels me to do something, it compels me to look back and see what it is that I can change…” said the Juno-award-winning musician.

“What is the most important (thing) is when a nation can look at another nation, or another group of people that are bleeding, and say that ‘that is my blood as well’ – that they can see outside of their particular experience and say ‘I am going to do something,’ because that is the human experience.”

The bill was first introduced in 2009 by former New Democrat MP Judy Wasylycia-Leis and was handed off to one of her colleagues when she retired. NDP Leader Jack Layton, who has been in hospital recovering from hip surgery, appeared in the House specially for the vote which passed with the help of the Bloc Quebecois, all but two Liberals, and a handful of Conservatives.

James Orbinski, the founder of Dignitas International, a medical humanitarian organization, pleaded with Senators to expedite it into law.

“It will save millions of lives, not in some distant future but literally within the next year or two,” said Dr. Orbinksi. The generic-drug maker Apotex has said that, if the legislation is successful, it will begin the production of a pediatric medicine to treat children in developing countries with HIV.

The Access to Medicines Regime was introduced by a former Liberal government as part of a pledge to help Africa’s poor. But the licences that it grants are severely limited and, in it’s seven-year-history, it has been used to send just two batches of a single drug to one developing country. Bill C-393 would eliminate many of the restrictions that the generic companies say have rendered the regime unworkable.

Those who oppose the legislation argue that it violates intellectual property rights and will dampen the enthusiasm of brand-name pharmaceutical companies to invest in medical research.

Brett Skinner, the president of the Fraser Institute who specializes in health policy research, said most developing countries do not register patents so Bill C-393 won’t change anything.

“Patents are not a barrier to access. And, when generic companies had access to these markets under previous provisions, they just simply did not ship their drugs to these (impoverished) countries,” said Mr. Skinner. There is a fear, he said, is that the cheap generic copies of these medicines will instead be sold to secondary markets like Hungary.

But Richard Elliott, the executive director of the Canadian HIV/AIDS Legal Network which has been a leading proponent of the bill, said patents do exist in some developing countries. And, in any case, it is against the law for Canadian generic manufacturers to copy and produce patented drugs here for sale abroad.

Stephen Lewis, the former United Nations special envoy for HIV/AIDS in Africa, said children and women who are infected with HIV are among those who have the most to gain from the passage of Bill C-393.

He pointed out that Prime Minister Stephen Harper, as chair of last year’s G-8 summit, launched an international maternal and child health initiative. “I can’t imagine anything,” he said, “that synchronizes more directly, that integrates more directly into his involvement in maternal and child care than would this legislation.”

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909